- Home
- FMY vs IOBT Comparison
FMY vs IOBT Comparison
Compare FMY & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMY
- IOBT
- Stock Information
- Founded
- FMY 2005
- IOBT 2014
- Country
- FMY United States
- IOBT Denmark
- Employees
- FMY N/A
- IOBT N/A
- Industry
- FMY Finance/Investors Services
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- FMY Finance
- IOBT Health Care
- Exchange
- FMY Nasdaq
- IOBT Nasdaq
- Market Cap
- FMY 51.0M
- IOBT 55.5M
- IPO Year
- FMY N/A
- IOBT 2021
- Fundamental
- Price
- FMY $11.98
- IOBT $0.73
- Analyst Decision
- FMY
- IOBT Buy
- Analyst Count
- FMY 0
- IOBT 4
- Target Price
- FMY N/A
- IOBT $3.50
- AVG Volume (30 Days)
- FMY 10.1K
- IOBT 1.3M
- Earning Date
- FMY 01-01-0001
- IOBT 11-14-2025
- Dividend Yield
- FMY 6.98%
- IOBT N/A
- EPS Growth
- FMY N/A
- IOBT N/A
- EPS
- FMY N/A
- IOBT N/A
- Revenue
- FMY N/A
- IOBT N/A
- Revenue This Year
- FMY N/A
- IOBT N/A
- Revenue Next Year
- FMY N/A
- IOBT N/A
- P/E Ratio
- FMY N/A
- IOBT N/A
- Revenue Growth
- FMY N/A
- IOBT N/A
- 52 Week Low
- FMY $10.71
- IOBT $0.32
- 52 Week High
- FMY $12.17
- IOBT $2.79
- Technical
- Relative Strength Index (RSI)
- FMY 43.08
- IOBT 43.44
- Support Level
- FMY $11.96
- IOBT $0.63
- Resistance Level
- FMY $12.06
- IOBT $0.84
- Average True Range (ATR)
- FMY 0.11
- IOBT 0.11
- MACD
- FMY -0.00
- IOBT -0.01
- Stochastic Oscillator
- FMY 39.69
- IOBT 26.01
About FMY First Trust Motgage Income Fund of Beneficial Interest
First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.